WDR12 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.382400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
4.121200E-01
Normal-vs-Stage2
4.242200E-01
Normal-vs-Stage3
8.909800E-01
Normal-vs-Stage4
2.616200E-02
Stage1-vs-Stage2
8.097200E-01
Stage1-vs-Stage3
5.129600E-01
Stage1-vs-Stage4
1.492600E-01
Stage2-vs-Stage3
4.252800E-01
Stage2-vs-Stage4
2.821000E-01
Stage3-vs-Stage4
6.989900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.529000E-01
Normal-vs-AfricanAmerican
1.533800E-01
Normal-vs-Asian
3.812000E-01
Caucasian-vs-AfricanAmerican
7.704600E-01
Caucasian-vs-Asian
8.392600E-01
AfricanAmerican-vs-Asian
5.850600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.342600E-01
Normal-vs-Female
5.073200E-01
Male-vs-Female
7.943000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
7.164800E-01
Normal-vs-Age(41-60Yrs)
3.544400E-01
Normal-vs-Age(61-80Yrs)
5.001200E-01
Normal-vs-Age(81-100Yrs)
2.675200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
2.622200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.923600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
2.082800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.333000E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.034400E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.314000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
6.632000E-01
Normal-vs-Daily Drinker
7.468200E-01
Normal-vs-Weekly Drinker
1.723590E-01
Normal-vs-Occasional Drinker
1.065650E-01
Normal-vs-Social Drinker
3.976200E-01
Non Drinker-vs-Daily Drinker
6.084800E-01
Non Drinker-vs-Weekly Drinker
3.692800E-01
Non Drinker-vs-Occasional Drinker
5.086600E-01
Non Drinker-vs-Social Drinker
8.951600E-01
Daily Drinker-vs-Weekly Drinker
2.850200E-01
Daily Drinker-vs-Occasional Drinker
1.292230E-01
Daily Drinker-vs-Social Drinker
4.574000E-01
Weekly Drinker-vs-Occasional Drinker
6.170800E-01
Weekly Drinker-vs-Social Drinker
4.694800E-01
Occasional Drinker-vs-Social Drinker
5.224000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
4.490200E-01
Normal-vs-Grade 2
1.998160E-01
Normal-vs-Grade 3
2.051000E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
2.058500E-03
Grade 1-vs-Grade 3
1.256580E-03
Grade 1-vs-Grade 4
4.490200E-01
Grade 2-vs-Grade 3
2.820400E-01
Grade 2-vs-Grade 4
1.998160E-01
Grade 3-vs-Grade 4
2.051000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
4.909200E-01
Normal-vs-NonDiabetic
5.233400E-01
Diabetic-vs-NonDiabetic
6.071600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.639400E-01
Normal-vs-NoPancreatitis
5.027000E-01
Pancreatitis-vs-NoPancreatitis
3.982000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
3.270600E-01
Normal-vs-N1
4.430000E-01
N0-vs-N1
5.598600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
1.500720E-03
Normal-vs-TP53-NonMutant
4.084400E-01
TP53-Mutant-vs-TP53-NonMutant
2.561000E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
